Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 49.14B 7.38B 6.59B 6.09B 5.52B 10.32B 702B 10.52B 73.32B 29.01B 367B 27.69B 27.1B 1,162B P/E 2026 *
37.9x
P/E 2027 * 28.4x
Enterprise Value 44.76B 6.72B 6B 5.55B 5.03B 9.4B 640B 9.59B 66.78B 26.42B 334B 25.22B 24.69B 1,059B EV / Sales 2026 *
5.55x
EV / Sales 2027 * 4.6x
Free-Float
62.13%
Yield 2026 *
0.92%
Yield 2027 * 1.29%
Manager TitleAgeSince
Chief Executive Officer 70 1998-10-06
Chief Executive Officer 49 2022-01-18
President - -
Director TitleAgeSince
Director/Board Member 49 2011-07-17
Chairman 70 1998-10-06
Director/Board Member 65 2011-07-17
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 7.7B
+0.45%+1.76%+54.96%+118.11% 1,135B
+0.94%+4.20%+39.86%+75.69% 635B
+0.39%+0.46%+25.77%+97.40% 505B
+1.43%+4.56%+46.20%+66.91% 378B
-3.21%-3.66%+60.72%+35.68% 358B
-0.41%+2.23%+22.48%+48.54% 295B
+0.23%+3.28%+2.57%+21.89% 266B
+1.22%+2.81%+52.40%+63.37% 237B
+1.70%+1.60%+31.21%+102.44% 193B
Average +0.52%+1.60%+37.35%+70.00% 444.85B
Weighted average by Cap. +0.42%+1.63%+41.40%+81.03%

Financials

2026 *2027 *
Net sales 8.06B 1.21B 1.08B 1B 906M 1.69B 115B 1.73B 12.03B 4.76B 60.22B 4.54B 4.45B 191B 9.89B 1.48B 1.33B 1.23B 1.11B 2.08B 141B 2.12B 14.75B 5.84B 73.85B 5.57B 5.45B 234B
Net income 1.33B 199M 178M 165M 149M 279M 18.97B 284M 1.98B 784M 9.92B 748M 732M 31.4B 1.78B 267M 238M 220M 200M 373M 25.4B 381M 2.65B 1.05B 13.27B 1B 980M 42.03B
Net Debt -4.38B -658M -588M -544M -492M -921M -62.65B -939M -6.54B -2.59B -32.74B -2.47B -2.42B -104B -3.66B -550M -491M -454M -411M -769M -52.32B -784M -5.46B -2.16B -27.34B -2.06B -2.02B -86.58B
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Asymchem Laboratories (Tianjin) Co., Ltd.